ATE328073T1 - Ehrlichia canis protein - Google Patents

Ehrlichia canis protein

Info

Publication number
ATE328073T1
ATE328073T1 AT99942504T AT99942504T ATE328073T1 AT E328073 T1 ATE328073 T1 AT E328073T1 AT 99942504 T AT99942504 T AT 99942504T AT 99942504 T AT99942504 T AT 99942504T AT E328073 T1 ATE328073 T1 AT E328073T1
Authority
AT
Austria
Prior art keywords
kda protein
canis
recombinant
ehrlichia
ehrlichia canis
Prior art date
Application number
AT99942504T
Other languages
English (en)
Inventor
David H Walker
Xu-Jie Yu
Original Assignee
Res Dev Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Res Dev Foundation filed Critical Res Dev Foundation
Application granted granted Critical
Publication of ATE328073T1 publication Critical patent/ATE328073T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/29—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Richettsiales (O)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT99942504T 1998-08-27 1999-08-27 Ehrlichia canis protein ATE328073T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/141,047 US6043085A (en) 1998-08-27 1998-08-27 Ehrlichia canis 120-kDa immunodominant antigenic protein and gene

Publications (1)

Publication Number Publication Date
ATE328073T1 true ATE328073T1 (de) 2006-06-15

Family

ID=22493934

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99942504T ATE328073T1 (de) 1998-08-27 1999-08-27 Ehrlichia canis protein

Country Status (17)

Country Link
US (1) US6043085A (de)
EP (1) EP1108014B1 (de)
JP (1) JP4550998B2 (de)
KR (1) KR100652469B1 (de)
CN (1) CN1281747C (de)
AT (1) ATE328073T1 (de)
AU (1) AU764853B2 (de)
BR (1) BR9913652B1 (de)
CA (1) CA2340462A1 (de)
DE (1) DE69931639D1 (de)
IL (2) IL141613A0 (de)
MX (1) MXPA01002042A (de)
NZ (1) NZ510103A (de)
RU (1) RU2232814C2 (de)
TW (1) TW557326B (de)
WO (1) WO2000012688A1 (de)
ZA (1) ZA200101440B (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020115840A1 (en) * 1998-11-30 2002-08-22 Walker David H. Homologous 28-kilodaltion immunodominant protein genes of Ehrlichia canis and uses thereof
US6392023B1 (en) * 1999-03-03 2002-05-21 Research Development Foundation Homologous 28-kilodalton immunodominant protein genes of Ehrlicha canis and uses thereof
US7335754B2 (en) * 1999-07-21 2008-02-26 Cornell Research Foundation, Inc. Ehrlichia canis genes and vaccines
US6355777B1 (en) * 2000-04-28 2002-03-12 Research Development Foundation P43 antigen for the immunodiagnosis of canine ehrlichiosis and uses thereof
WO2001083699A2 (en) * 2000-05-01 2001-11-08 Research Development Foundation Ehrlichia chaffeensis 28 kda outer membrane protein multigene family
US7204992B2 (en) * 2002-11-04 2007-04-17 Clayton Foundation For Research P153 and P156 antigens for the immunodiagnosis of canine and human ehrlichioses and uses thereof
US20050202046A1 (en) * 2004-03-11 2005-09-15 Wyeth Canine vaccine for protection against ehrlichiosis
ES2928463T3 (es) 2005-04-04 2022-11-18 Idexx Lab Inc DIVA (que diferencia animales infectados de vacunados) de Ehrlichia canis
US7842474B2 (en) * 2005-04-04 2010-11-30 Idexx Laboratories, Inc. Ehrlichia canis DIVA (differentiate infected from vaccinated animals)
ES2618842T3 (es) 2007-09-11 2017-06-22 Yissum Research Development Company Of The Hebrew University Of Jerusalem Vacuna atenuada para la erliquiosis
WO2009039413A2 (en) 2007-09-21 2009-03-26 Idexx Laboratories, Inc. Methods and compositions for detection of ehrlichia chaffeensis (p120)
CA2700476C (en) * 2007-09-21 2017-11-28 Idexx Laboratories, Inc. Methods and compositions for detection of ehrlichia chaffeensis variable-length pcr target
EP2045816A1 (de) * 2007-10-01 2009-04-08 Paul Scherrer Institut Schnelles Auslesungsverfahren und Schaltkondensator-Arrayschaltung zur Wellenform-Digitalisierung
CZ2007716A3 (cs) 2007-10-15 2009-04-29 Elmarco S. R. O. Zpusob výroby nanovláken
KR101621038B1 (ko) * 2007-10-31 2016-05-16 아이덱스 래보러토리즈, 인코포레이티드 에를리히아 카니스 ｄｉｖａ（감염된 동물을 백신접종된 동물과 구별）
KR101010432B1 (ko) * 2008-08-30 2011-01-21 이영수 여과기
DK2424880T3 (en) * 2009-04-28 2016-10-24 Res Dev Foundation Immunoreactive Ehrlichia p120 / p140 epitopes, and uses thereof
WO2011063235A2 (en) * 2009-11-20 2011-05-26 Abaxis, Inc. Peptides, devices, and methods for the detection of ehrlichia antibodies
RU2603274C2 (ru) * 2010-07-02 2016-11-27 Интервет Интернэшнл Б.В. Вакцина против ehrlichia canis
JP6325553B2 (ja) 2012-10-11 2018-05-16 アバクシス， インコーポレイテッド エールリヒア抗体の検出のためのペプチド、デバイス、および方法
US9442112B2 (en) 2014-04-04 2016-09-13 Abaxis, Inc. Compositions and methods for identifying Ehrlichia species
CN112703197A (zh) * 2018-07-27 2021-04-23 研究发展基金会 嵌合免疫原性多肽
MX2022000525A (es) * 2019-07-12 2022-04-20 Res Found Dev Vacunas contra la ehrlichia y composiciones inmunogenicas.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6015691A (en) * 1996-05-31 2000-01-18 Research Development Foundation Immunodominant 120 kDa surface-exposed adhesion protein genes of Ehrlichia chaffeensis

Also Published As

Publication number Publication date
NZ510103A (en) 2004-10-29
US6043085A (en) 2000-03-28
EP1108014A1 (de) 2001-06-20
TW557326B (en) 2003-10-11
WO2000012688A1 (en) 2000-03-09
ZA200101440B (en) 2002-01-30
MXPA01002042A (es) 2002-06-21
CN1281747C (zh) 2006-10-25
IL141613A (en) 2010-05-31
EP1108014B1 (de) 2006-05-31
JP2002523087A (ja) 2002-07-30
BR9913652A (pt) 2001-06-05
IL141613A0 (en) 2002-03-10
CA2340462A1 (en) 2000-03-09
EP1108014A4 (de) 2004-12-15
KR20010072997A (ko) 2001-07-31
DE69931639D1 (en) 2006-07-06
JP4550998B2 (ja) 2010-09-22
AU5586499A (en) 2000-03-21
BR9913652B1 (pt) 2014-02-18
KR100652469B1 (ko) 2006-12-01
CN1321190A (zh) 2001-11-07
AU764853B2 (en) 2003-09-04
RU2232814C2 (ru) 2004-07-20

Similar Documents

Publication Publication Date Title
ATE328073T1 (de) Ehrlichia canis protein
AR047347A1 (es) Miembros de la familia cry9 de bacillus
DE69938302D1 (de) Neisseria meningitidis antigene und zusammenstellungen
CY1106806T1 (el) Dna και πολυπεπτιδια ανθρωπινης tslp
DE60144145D1 (de) Subtilisin-variante
DK1090033T4 (da) Partikler af HCV-kappeproteiner: Anvendelse til vaccination
DK0652287T3 (da) Poxvirale vektorer og deres anvendelse som en vaccine mod felin infektiøs peritonotos-virussygdom
ATE323164T1 (de) Oberfläche-exponierte proteine von chlamydia pneumoniae
ATE482272T1 (de) Zytokinproteinfamilie
ATE469170T1 (de) Zusammensetzungen und verfahren mit dem respiratory syncytial virus untergruppe b stamm 9320
ATE543513T1 (de) Anti-coronavirus impfstoff
DE60139959D1 (de) Nukleinsäureadjuvantien
SE9602822D0 (sv) New receptor
DK0778894T3 (da) Vaccine mod infektiös felin peritonitis
ATE344802T1 (de) Angiogenese-assoziierte proteine und dafür kodierende nukleinsäure
BR0010222A (pt) Vetores de expressão viral
DE60229966D1 (de) Diabetesmodell
MY137258A (en) Bacterial insecticidal protein
ATE298348T1 (de) Mutmassliches 98 kd protein des aussenmembrans von chlamydia und dafür kodierende dns sowie deren verwendung
MXPA01007582A (es) Control de infeccion por virus utilizando proteinas asociadas de replicacion, composiciones y metodos de uso.
TH54286B (th) สายพันธุ์ไคเมอริค IBDV ซีโรไทพ์ (serotype chimeric IBDV strains)
TH57274B (th) การก่อภูมิคุ้มกันของวัวนมด้วยโปรตีน GapC ต่อต้านการติดเชื้อ สเทรปโทคอกคัส
TH54286A (th) สายพันธุ์ไคเมอริค IBDV ซีโรไทพ์ (serotype chimeric IBDV strains)

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties